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Abstract 
Primary thyroid lymphoma is a rare malig-
nancy, representing 2-8% of all thyroid malig-
nancies and 1-2% of all extranodal lymphomas.
The majority of cases concern non-Hodgkin’s
lymphoma  of  B  cell  origin,  following  by
Hodgkin’s disease, T cell lymphomas and rarely
marginal zone B-cell mucosa-associated lym-
phoid tissue (MALT) lymphomas. MALT lym-
phomas have been associated with long-stand-
ing autoimmune Hashimoto’s thyroiditis. We
present the case of a 44-years-old woman with
thyroid MALT lymphoma in the background of
multinodular goiter of autoimmune origin.
Introduction
Primary thyroid lymphoma represents 2-8%
of  all  thyroid  malignancies  and  1-2%  of  all
extranodal  lymphomas.1-3 Most  thyroid  lym-
phomas  are  non-Hodgkin’s  lymphomas  of  B
cell origin, following by Hodgkin’s disease, T
cell lymphomas and rarely marginal zone B-cell
mucosa-associated  lymphoid  tissue  (MALT)
lymphomas.1-3 MALT  lymphomas,  which
account for 25% of primary lymphomas, arise
mainly in the stomach (60-70%), but they also
can be found in organs such as the orbit, sali-
vary gland, lung, intestine, liver and thyroid
gland.2 Normally,  thyroid  gland  is  devoid  of
lymphoid tissue while this is reversed during
the course of autoimmune diseases such as
Hashimoto’s thyroiditis.1-3 It has been evident
that thyroid MALT lymphomas occur in 0.5% of
the cases with Hashimoto’s thyroiditis, even
after a long period of lymphocytic infiltration
which reaches as long as 30 years. A concur-
rence  with  papillary  thyroid  carcinoma  has
been also reported4,5 The clinical presentation
include  an  enlarging  neck  mass,  dysphagia,
hoarseness, dyspnea and usually the patients
are euthyroid. Most often the diagnosis is dif-
ficult,  based  either  on  the  morphological  or
clinical  characteristics  and  flow  cytometry,
Southern  blotting  or  PCR  need  to  be  per-
formed.6-8
Herein, we describe the case of a 44-years-
old  female  who  was  diagnosed  with  thyroid
MALT lymphoma in the background of autoim-
mune thyroiditis.
Case Report
A-44 years-old, obese, woman, with autoim-
mune  thyroiditis  on  L-thyroxine  treatment
(100 ug/d), was referred to our department for
further evaluation of a rapidly growing mass of
the right lobe of the thyroid gland, associated
with  gradually  increased  pain  and  dyspnea.
The  laboratory  evaluation  of  the  patient
revealed normal TSH levels and positive thy-
roid antibodies, indicating a properly treated
autoimmune thyroiditis. A Doppler ultrasound
of the thyroid gland revealed multiple hypoe-
choic nodules (max. diam 2 cm) with microcal-
cifications and increased peripheral and cen-
tral vascularity. A fine needle aspiration was
performed,  which  showed  suspicious  for
malignancy findings of the nodule while a lym-
phoproliferative  infiltration  of  the  thyroid
parenchyma  and  histiocytes,  mainly  with
epithelioid  morphology,  were  also  observed.
Her sister and her mother had the diagnosis of
occult  papillary  thyroid  cancer  on  the  back-
ground of autoimmune thyroiditis, which had
been diagnosed at the age of 35 years.
Due to the suspicious ultrasound and cyto-
logic findings, the positive for thyroid cancer
family history and the difficulty of having a
systematic follow up, total thyroidectomy was
performed.  The  pathology  showed  thyroid
MALT lymphoma on the background of autoim-
mune Hashimoto’s thyroiditis. More specifical-
ly,  the  H&E  staining,  in  addition  to  chronic
lymphocytic thyroiditis, showed a characteris-
tic infiltration of the thyroid tissue with mono-
clonal plasma cells and big epithelial histio-
cytes.  The  immunohistochemical  study
revealed monoclonal cytoplasmic immunoglob-
ulin expression of cIg-λ in the plasma cell pop-
ulation (Figure 1).
The  patient  underwent  further  evaluation
with gastroscopy and scanning tomography of
the neck, thorax and pelvis which were all neg-
ative. Bone marrow biopsy reported a reactive
marrow and the immunohistochemical study
(anti-CD3/CD20/CD138, Glycoporin A, κ and λ
light chain immunoglobulin) was negative for
the presence of MALT lymphoma. 
The potential benefits of being further treat-
ed by radiotherapy and/or chemotherapy, were
discussed with the oncologists and the final
decision was the annual follow up. Two years
after she is well, with no evidence of local or
systematic disease, adequately replaced with
L-thyroxine 
Discussion
The present report, refers to a patient with
thyroid MALT lymphoma on the background of
autoimmune thyroiditis. 
Primary thyroid MALT lymphoma is a quite
rare neoplasm accounting for 2-8% of all thy-
roid malignancies and 1-2% of all extranodal
lymphomas.1-3 It  tends  to  present  in  women
during their seventh decade of life, while our
case refers to a middle-aged woman. Men with
thyroid MALT lymphoma, exhibit a worse prog-
nosis, compared to the well differentiated thy-
roid cancer.1-3,9
Most  commonly,  it  presents  as  a  painless
rapidly growing thyroid mass, as in our case,
while general symptoms like fever, nocturnal
sweating and weight loss mostly suggest sec-
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ondary  thyroid  infiltration  by  lymphoma  of
another organ.1-3,8,9
Although H. pylori infection has been asso-
ciated with gastric MALT lymphoma in addition
to coronary artery disease and type 1 and 2 dia-
betes  mellitus10-13 this  relationship  has  not
been adequately addressed for thyroid MALT
lymphoma.  The  existing  data  support  that
autoimmune thyroiditis seems to be a risk fac-
tor for the development of thyroid MALT lym-
phoma due to an acquired pathological trans-
formation of the intrathyroidal lymphoid tis-
sue.14 Most often the concurrence of thyroid
MALT lymphoma with autoimmune thyroiditis
creates a lot of problems in its diagnosis. In
autoimmune thyroiditis the two main micro-
scopical findings are lymphocytic infiltration
of the stroma and oxyphilic change of the fol-
licular epithelium. On the other side, the char-
acteristics of thyroid MALT lymphoma include
the atypical lymphoid cells originated within
the marginal zone of the lymphoid follicles and
extended into the interfollicular space, the thy-
roid  follicular  epithelium  and  the  germinal
centers.  In  certain  cases,  immunocytochem-
istry (CD 20, CD 43, λ- and κ- light chains),
but also flow cytometry and PCR, are needed to
confirm  the  diagnosis  of  thyroid  MALT  lym-
phoma.7-9,15
A lot of questions have been raised regard-
ing the follow up of patients with thyroid MALT
lymphomas. The first step consists of a careful
systematic evaluation of the patient in order to
characterize  the  thyroid  MALT  lymphoma  as
primary.  This  includes  a  thorough  physical
examination, a full biochemical investigation,
evaluation of the gastrointestinal tract (gas-
troscopy, colonoscopy), a bone marrow biopsy
and scanning of the neck, chest and abdomen.
The second step is the staging of the tumor
according to the system proposed by Ann Arbor
and modified by Myssoff.7,16,17
Many dilemmas have been raised regarding
the proper management of patients with thy-
roid  MALT  lymphoma.  Retrospective  reports
suggest  an  indolent  behavior  and  excellent
clinical  prognosis  for  this  subset  of  thyroid
lymphomas, leading to the conclusion that sin-
gle  modality  therapy  with  either  surgery  or
radiation may have a treatment role. However,
in the absence of randomized clinical trials to
compare  different  treatment  options  (thy-
roidectomy,  radiotherapy,  chemotherapy)  in
patients with thyroid MALT lymphoma, there
are not widely accepted guidelines and thus
therapeutical protocols should be planned in
an individual base. Total thyroidectomy is the
treatment of choice in patients with compres-
sive  goiter  and  localized  thyroid  MALT  lym-
phoma. Radiotherapy is used as primary thera-
py in patients with stage IE and IIE and as
adjuvant  therapy  for  those  with  suspected
residual  disease  after  thyroidectomy.
Chemotherapy is usually indicated for patients
with disease stages IIIE and IV but prognostic
data are unavailable because of the rarity of
this condition. In patients with localized dis-
ease, as in our patient, the preferred treatment
is total thyroidectomy while the benefit from
applying radiotherapy in a total dose of 40 Gy,
or chemotherapy, is questionable and with its
toxicity being a major issue.1,2,6,8,17-20
In conclusion, our case of a concurrence of
primary thyroid MALT lymphoma and autoim-
mune thyroiditis, is trying to emphasize the
need of a careful evaluation of any palpable
thyroid mass. This could be a benign lesion but
also  a  malignant  lesion,  including  not  only
neoplasms of thyroid tissue but also metastat-
ic from other sites or primary neoplasms of
extrathyroidal  origin,  as  the  case  of  lym-
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Figure 1. A) Hematoxylin and eosin (H&E) staining showing mucosa-associated lym-
phoid tissue (MALT) thyroid lymphoma; B) immunohistochemical evaluation reported
MALT-balls; C) D) E) F) G) serial sections immunostained for CD79+, CD20+, cIg-κ,
cIg-λ, L26, respectively.[page 6] [Rare Tumors 2012; 4:e2]
phomas  and  rarely  MALT  lymphomas.
Moreover, this case in addition to the existing
published cases, illustrates that the nature of
follow-up care and long-term results of treat-
ment of patients with primary thyroid MALT
lymphomas are not fully established.
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